OPRX Q2 2023 Earnings — OptimizeRx Corporation Revenue & Financial Results | Market Cap Arena

OPRXOptimizeRx Corporation

$128M

Q2 2023 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$14M-1.1% YoY

Gross Profit

$8M56.6% margin

Operating Income

-$5M-35.1% margin

Net Income

-$4M-30.1% margin

EPS (Diluted)

$-0.24

QoQ Revenue Growth

+6.3%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$121M

Total Liabilities

$6M

Stockholders' Equity

$116M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$14M	-1.1%
Gross Profit	$8M	$9M	-13.0%
Operating Income	-$5M	-$4M	-24.1%
Net Income	-$4M	-$4M	-7.1%